Treatment of Hypovitaminosis D in Post-Renal Transplant Patients

Initial Assessment and Diagnosis

The American Journal of Kidney Diseases recommends measuring serum 25-hydroxyvitamin D [25(OH)D] levels at first encounter post-transplant and annually thereafter if normal 2
Vitamin D deficiency is defined as 25(OH)D <20 ng/mL, while insufficiency is 20-30 ng/mL, according to the American Journal of Kidney Diseases 3
The target 25(OH)D level should be at least 30 ng/mL (75 nmol/L) for optimal bone health, cardiovascular protection, and graft outcomes, as recommended by the American Journal of Kidney Diseases 3

For vitamin D deficiency (<20 ng/mL), the American Journal of Kidney Diseases recommends administering ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) 50,000 IU once weekly for 8-12 weeks 6, 2
Cholecalciferol (D3) is preferred over ergocalciferol (D2) as it maintains serum levels longer and has superior bioavailability, according to the American Journal of Kidney Diseases 3, 7
After achieving target levels, the American Journal of Kidney Diseases recommends continuing with 800-2,000 IU daily or 50,000 IU monthly 1, 3, 4

The American Journal of Kidney Diseases recommends measuring serum calcium and phosphorus at least every 3 months after initiating vitamin D therapy 2
Recheck 25(OH)D levels after 3-6 months of treatment to confirm adequate response, as recommended by the American Journal of Kidney Diseases 3
Monitor serum parathyroid hormone (PTH) levels every 3 months for 6 months, then every 3 months thereafter, according to the American Journal of Kidney Diseases 6

The American Journal of Kidney Diseases recommends discontinuing vitamin D therapy if serum corrected total calcium exceeds 10.2 mg/dL (2.54 mmol/L) or serum phosphorus exceeds 4.6 mg/dL (1.49 mmol/L) despite phosphate binder therapy 2
Daily doses up to 4,000 IU are generally safe for adults, according to the American Journal of Kidney Diseases 6, 5, 3
The upper safety limit for 25(OH)D is 100 ng/mL, as recommended by the American Journal of Kidney Diseases 3, 4

Ensure adequate calcium intake of 1,000-1,500 mg daily from diet plus supplements if needed, as recommended by the American Journal of Kidney Diseases 3, 7
Calcium supplements should be taken in divided doses of no more than 600 mg at once for optimal absorption, according to the American Journal of Kidney Diseases 3

The American Journal of Kidney Diseases recommends not using active vitamin D analogs (calcitriol, alfacalcidol, doxercalciferol, paricalcitol) to treat nutritional vitamin D deficiency 2, 3
Active vitamin D analogs are reserved for specific indications such as persistent hyperparathyroidism despite adequate 25(OH)D levels, according to the American Journal of Kidney Diseases 6, 2
Nutritional vitamin D (cholecalciferol or ergocalciferol) is the appropriate first-line treatment for low 25(OH)D levels, as recommended by the American Journal of Kidney Diseases 1